Target intelligence / Profile preview

Vacuolar protein sorting-associated protein 13A (VPS13A)

Target
VPS13A
Molecular classification
Other (large intermembrane lipid transfer protein), Lipid transfer protein, Peripheral membrane protein, Repeating beta groove (RBG) superfamily
01

Overview

Vacuolar protein sorting-associated protein 13A (VPS13A) is a very large, multi-domain lipid transfer protein found primarily at membrane contact sites between the endoplasmic reticulum, mitochondria, and lipid droplets[1][2][3]. It establishes inter-organelle connections, especially between the ER and mitochondria, through its FFAT motif binding to VAP-A/B and its C-terminal anchoring to the mitochondrial outer membrane[1][3]. VPS13A contains several structural domains, including an N-terminal chorein domain critical for actin cytoskeleton regulation, a lipid-binding domain for lipid shuttling, HEAT repeats, and a C-terminal pleckstrin homology (PH) domain[2][3]. Its evolutionarily conserved function is the bulk transfer of lipids between bilayers, which is essential for proper organelle function and membrane biogenesis. Loss-of-function mutations in the VPS13A gene result in Chorea-acanthocytosis, a severe neurodegenerative disease characterized by movement disorders (chorea), red blood cell abnormalities (acanthocytosis), and progressive neurodegeneration[1][2]. There are no known drugs that directly target VPS13A, but the protein is of interest for future therapeutic targeting due to its central role in organelle biology and implication in rare inherited diseases[1][3].

Other names
Intermembrane lipid transfer protein VPS13AChoreinChorea-acanthocytosis proteinBridge-like lipid transfer protein family member 5ABLTP5ACHACKIAA0986Vacuolar protein sorting 13 homolog AVacuolar protein sorting 13A
02

Biological functions

Lipid transfer between organellesOrganelle contact site formationRegulation of actin cytoskeleton dynamicsAutophagy/mitophagy regulationProtein homeostasisLipid droplet biology
03

Disease associations

Neurodegenerative disease (notably Chorea-acanthocytosis)Other neurological disorders
04

Safety considerations

Mutations disrupt organelle lipid exchangerisk of complex neurological disorders (Chorea-acanthocytosis)potential secondary metabolic defects due to organelle dysfunction

Beyond the preview

Go deeper on Vacuolar protein sorting-associated protein 13A (VPS13A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar protein sorting-associated protein 13A (VPS13A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call